Koselugo OverviewSelumetinib (INN), sold under the brand name Koselugo, is a medication for the treatment of children, two years of age and older, with neurofibromatosis type I (NF1), a genetic disorder of the nervous system causing tumors to grow on nerves. It is taken by mouth twice per day on an empty stomach. Common side effects are vomiting, rash, abdominal pain, diarrhea, nausea, dry skin, fatigue, musculoskeletal pain (pain in the body affecting ...
Read more Koselugo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Selumetinib
Recent Koselugo Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Capsule: 10mg, 25mg
NDC Database Records for Koselugo: (2 results)Sorted by National Drug Code
- 0310-0610 Koselugo 10 mg Oral Capsule by Astrazeneca Pharmaceuticals Lp
- 0310-0625 Koselugo 25 mg Oral Capsule by Astrazeneca Pharmaceuticals Lp